HC Wainwright & Co. analyst Sean Lee downgrades Kazia Therapeutics (NASDAQ:KZIA) from Buy to Neutral.
Israel-Hamas Conflict: Here’s How Zuckerberg’s Meta Handling Content Moderation Vs. Musk’s X
Meta's Chris Cox, discussed the company's proactive content moderation strategy during the Israel-Hamas conflict.